Elaine Chen covers biotech, co-writes The Readout newsletter, and co-hosts STAT’s weekly biotech podcast, The Readout Loud. You can reach Elaine on Signal at elaineywchen.70. Novo Nordisk’s obesity ...

Drug developers with products targeting a liver condition called metabolic dysfunction-associated steatohepatitis (MASH) traded higher on Wednesday after the U.S. FDA said it has accepted an ...

The combination of ervogastat plus clesacostat was more effective at resolving metabolic dysfunction-associated steatohepatitis (MASH) without worsening fibrosis in patients with biopsy-confirmed MASH ...

#1 insurer: 1 out of 3 insured riders choose Progressive. Savings: We offer plenty of discounts, and rates start at just $75/year. OEM parts in repairs: We use OEM parts in repairs and don’t ...

Roche dived into the metabolic dysfunction-associated steatohepatitis (MASH) space by agreeing to hand over up to $3.5 billion for 89bio and its phase-3-stage candidate for the fatty liver disease. At ...

In adults with metabolic dysfunction-associated steatohepatitis (MASH), 20 weeks of moderate-intensity aerobic exercise led to disease resolution more than twice as often as standard care, as well as ...